Proteomics International: Raises $6M for high-tech blood test

  • Proteomics International (PIQ) has received firm commitments to undertake a $6 million share placement
  • 12.5 million shares will issued to sophisticated and professional investors at 48 cents each
  • Additionally, the company will issue 2.2 million options to Euroz Hartleys Securities and Candour Advisory
  • These options will have an exercise price of 75 cents with expiry two years after issue
  • Proteomics will also use the funds to manufacture, market, and speed-up regulatory approvals for its PromarkerD test and strengthen its balance sheet
  • Proteomics is up 9 per cent on the market with shares trading for 60 cents each
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FCA Launches Pop-Up ATM to Warn Customers of Investment Scams

New initiative aims to educate the public on investment fraud risks. Highlights:FCA introduces a pop-up ATM to combat...

Lloyds Strengthens AI Strategy After Assessing Financial Value of Deployments

The bank plans to enhance its artificial intelligence capabilities further.Highlights: Lloyds assesses the financial value of its AI...

Santander Tightens Operations with Closure of 44 More Branches

The bank continues its restructuring as customer preferences shift to digital banking.Highlights: Santander is closing 44 more branches...

Stablecoin Bank Kontigo Suffers Cyber Attack, Disrupting Operations

The cyber incident raises concerns about security in fintech.Highlights: Kontigo, a prominent stablecoin bank, experienced a cyber attack.The...